Special Research Coverage Episodes

This week, we're talking about shady stem cell clinics and their shady clinical trials. We'll tell you about a study that makes a connection between stress-related disorders and autoimmune disease, and a research team that may have identified the possible genetic causes of MS. My guest is Dr. Laura Rice, an expert in rehabilitation science and technology at the University of Illinois, Urbana-Champagne. Dr. Rice's focus is on maximizing the quality of life and community participation among wheel...

Stem Cells are in the news, and we're talking about the U.S. District Court decision that will impact hundreds of stem cell clinics in the United States and the FDA's ability to regulate them. We'll also share two breakthroughs in stem cell research that will likely impact the future of stem cell therapy. My guest on the podcast is Dr. Karen Lee, the Vice-President of Research at the MS Society of Canada. Canada has one of the highest rates of MS in the world, and the MS Society of Canada has r...

MS research scientist Dr. Jeffrey Huang is this year's recipient of the Harry Weaver Neuroscience Scholar Award from the National MS Society. On this week's podcast, we're talking with Dr. Huang about his potentially groundbreaking research, and we'll even ask him how one becomes an MS research scientist. We're also talking about the lectures, presentations, and education sessions that took place last week at the Consortium of Multiple Sclerosis Centers Annual Meeting. We'll explain why we don'...

We're at the Consortium of Multiple Sclerosis Centers Annual Meeting in Seattle, Washington, talking about mental health care for people living with MS, coping with anxiety, and the real advantages of telerehabilitation. We even sat down to talk with with artist and MS Activist Lydia Emily. We have a lot to talk about! Are you ready for RealTalk MS??!

We're at the Consortium of Multiple Sclerosis Centers Annual Meeting in Seattle, Washington, and we're talking about community based programs to enhance comprehensive MS care, understanding the MS care partner's perspective, improving MS treatment outcomes, and more. We have a lot to talk about! Are you ready for RealTalk MS??!

We're at the Consortium of Multiple Sclerosis Centers Annual Meeting in Seattle, Washington, and we're talking about MS Navigators, Myelocortical MS, a new paradigm in how patients and doctors should be communicating, and more. We have a lot to talk about! Are you ready for RealTalk MS??!

The International Progressive MS Alliance is an unprecedented and unparalleled global effort to understand and treat progressive MS. Last week, I was in Copenhagen, Denmark, for an important meeting of the Progressive MS Alliance Scientific Steering Committee. And in today's episode, I'll update you on the status of three potentially breakthrough progressive MS international research projects. Don't forget! World MS Day is Thursday, May 30, and we're talking with MS International Federation CE...

We're at the American Academy of Neurology Annual Meeting in Philadelphia, and we're talking about teleneurology, stem cells, a new algorithm, and a new research network with ambitious goals. Today, it's a real peek into the future! We have a lot to talk about! Are you ready for RealTalk MS??!

Get the latest news from the American Academy of Neurology Annual Meeting. We're looking into the future of applying precision medicine to treat MS. We're talking about an artificial intelligence application that's designed to predict the course of your MS and recommend the best treatment plan for you We'll also tell you about a "digital prescription therapeutic" designed to treat depression in people living with MS. And researchers are also looking at better understanding the recent past, as a...

It's my first day at the American Academy of Neurology Annual Meeting, and we're talking about a great presentation on Progress in Progressive MS and some eye-opening news about the amount of money we're spending in the U.S. on prescription drugs to treat neurological conditions.